By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Amarantus BioSciences, Inc.  

675 Almanor Avenue

Sunnyvale  California  94085  U.S.A.
Phone: 408-737-2734 Fax: 408-852-4427


SEARCH JOBS


Industry
Biotechnology






Company News
Amarantus BioSciences, Inc. Announces Issuance Of United States Patent No. 9,066,903 Covering Proprietary Methods Of Administration Of Eltoprazine For The Treatment Of Parkinson's Disease 6/30/2015 7:24:45 AM
Amarantus BioSciences, Inc. To Present At The BIO International Convention 6/10/2015 8:00:48 AM
Amarantus BioSciences, Inc. Completes Capital Restructuring In Preparation For National Exchange Listing 6/10/2015 7:27:02 AM
Amarantus BioSciences, Inc. Opens First Clinical Trial Site And Commences Patient Enrollment For Lead Product Candidate Eltoprazine's Phase IIb Study In Parkinson's Disease Levodopa-Induced Dyskinesia 6/5/2015 7:17:34 AM
Amarantus BioSciences, Inc. To Present At The Fourth Annual SeeThru Equity Microcap Investor Conference On May 28, 2015 5/26/2015 7:57:17 AM
Amarantus BioSciences, Inc. Effects Capital Restructuring In Anticipation Of National Exchange Listing 5/22/2015 6:11:49 AM
Amarantus BioSciences, Inc. Enters Into CRO Agreement With Chiltern International Ltd. To Commence Phase IIb Clinical Development Of Eltoprazine In Parkinson's Disease Levodopa-Induced Dyskinesia 5/21/2015 11:01:01 AM
Amarantus BioSciences, Inc. Reports First Quarter 2015 Financial Results And Business Overview 5/20/2015 11:49:12 AM
Amarantus BioSciences, Inc. To Present At Two Upcoming Investor Conferences 5/20/2015 8:24:33 AM
Amarantus BioSciences, Inc. Announces Successful Delivery And Distribution Of MANF In Preclinical Model To Brain Areas Involved In Parkinson's Disease 5/15/2015 7:07:14 AM
12345678910...
//-->